Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials. [electronic resource]
Publication details: Therapeutic advances in gastroenterology 2019Description: 1756284819841290 p. digitalISSN:- 1756-283X
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.